Valgen Medtech Funding: $158M Raised, Series B (2021)

Valgen Medtech funding overview

Valgen Medtech is based in Hangzhou, Zhejiang, China. Valgen Medtech has raised $158M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in May 2021. The round record for Valgen Medtech runs through 2021; nothing later has been disclosed. Investors on record include BioTrack Capital, Shanghai INT Medical Instruments, Ascendum Capital, China Life Private Equity, DCP Capital. 5 distinct backers are named across the disclosed rounds.

Valgen Medtech at a glance

Total raised: $158M
Latest round: Series B
Latest round date: May 2021
Headquarters: Hangzhou, Zhejiang, China
Notable investors: BioTrack Capital, Shanghai INT Medical Instruments, Ascendum Capital, China Life Private Equity, DCP Capital

Frequently asked about Valgen Medtech funding

How much has Valgen Medtech raised?: Valgen Medtech has raised $158M in total disclosed funding across the rounds on record.
Who has invested in Valgen Medtech?: BioTrack Capital, Shanghai INT Medical Instruments, Ascendum Capital, China Life Private Equity, DCP Capital are named among the investors backing Valgen Medtech.
What was the latest Valgen Medtech funding round?: The most recent disclosed round is a Series B, announced in May 2021.
Where is Valgen Medtech based?: Valgen Medtech is based in Hangzhou, Zhejiang, China.
When did Valgen Medtech last raise?: The last disclosed Valgen Medtech round closed in May 2021 at Series B.

Round data for Valgen Medtech is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Hangzhou and backer lists below.

Valgen Medtech Funding: $158M Raised, Series B (2021)

Valgen Medtech funding overview

Valgen Medtech at a glance

Frequently asked about Valgen Medtech funding

Companies related to Valgen Medtech (36)

Browse related funding lists (3)